WASHINGTON (dpa-AFX) – Allergan Aesthetics, part of AbbVie (ABBV), on Friday said the European Commission approved Boey for the temporary improvement of moderate to severe glabellar lines, or frow…
EU Approves Allergan Aesthetics’ Boey For Treatment Of Frown Lines
Source: Finanznachrichten.de
Read Full Story →
